Amryt Pharma PLC (LON:AMYT)

Amryt Pharma PLC (LON:AMYT)

Share Price
12.38 p
0 (-2.94 %)
Market Cap
£34.01 m
Proactive Investors - Run By Investors For Investors

Amryt Pharma PLC

Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases.

Market: AIM:AMYT
52-week High/Low: 20.30p / 11.65p
Sector: Pharmaceuticals
Market Cap: £34.01 m
col 3
col 4
col 5
col 6

Amryt Pharma PLC RNS Announcements

Date Epic Announcement
22/05/2019 AMYT Grant of Options
21/05/2019 AMYT Suspension - Amryt Pharma plc
21/05/2019 AMYT Euronext Growth Dublin Suspension Notice
21/05/2019 AMYT Recommended Acquisition of Aegerion
17/04/2019 AMYT Preliminary Results and Q1 Trading Update
12/04/2019 AMYT Notice of Results
28/02/2019 AMYT Update on AP101 EASE Phase III trial
07/01/2019 AMYT Positive results for gene therapy AP103
04/01/2019 AMYT EASE Phase III trial interim efficacy results
21/12/2018 AMYT Second Price Monitoring Extn
21/12/2018 AMYT Price Monitoring Extension
19/12/2018 AMYT Update on ongoing AP101 Trial
10/12/2018 AMYT Grant Funding from Irish Government for AP103
17/10/2018 AMYT Lojuxta to be reimbursed in France
26/09/2018 AMYT Interim Results
14/09/2018 AMYT Notice of Results
10/09/2018 AMYT Amryt receives IND approval from FDA for AP101
02/08/2018 AMYT FDA grants Pediatric Rare Disease designation
19/07/2018 AMYT Trading update & significant momentum building
09/07/2018 AMYT NHS England approves funding for Lojuxta
06/07/2018 AMYT Change of Registered Address
25/06/2018 AMYT Company name alteration for previous release
25/06/2018 AMYT Positive data of Pollinex Quattro Grass vaccine
05/06/2018 AMYT Result of AGM
29/05/2018 AMYT Four Middle East Lojuxta® Distribution Agreements
10/05/2018 AMYT Exclusive Lojuxta® Licence Expanded
09/05/2018 AMYT Holding(s) in Company
08/05/2018 AMYT Holding(s) in Company and Lock-in agreement
04/05/2018 AMYT Posting of Annual Report 2017 and Notice of AGM
17/04/2018 AMYT Final Results
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use